Tweet
Two Shooto Brazil Fighters Suspended Two Years for Steroids
October 9, 2015
The Brazilian Athletic Commission MMA (CABMMA) reports that four athletes were subjected to doping control tests to detect prohibited substances, per the code of the World Anti-Doping Agency (WADA), at Shooto Brazil 56, held in Rio de Janeiro on Aug. 21.
Two of the four fighters tested returned positive results.
Fabio Lima Ferreira tested positive for the stimulant methylhexaneamine and for the anabolic steroid stanozolol. Ferreira decided not to appeal the positive test results and received a two-year suspension. Ferreira lost by knock out to Mario Sartori in the fight card’s co-main event.
Main event fighter Amilcar Alves returned a positive test for 19-norandrosterone, a metabolite of the anabolic steroid nandrolone. The athlete plans to have his B sample tested to confirm the results, but his win was overturned and he received a two-year suspension. He was also forced to relinquish the welterweight title to his opponent, Rafael Viana.
The analysis of the tests was conducted at the UCLA Olympic Analytical Laboratory, and INRS-Institut Armand-Frappier, in the U.S. and Canada (certified laboratories WADA), respectively.
CABMMA is a member and follows the guidelines of the Association of Boxing Commission (ABC), and also adheres to the new anti-doping control policy of the United States Anti-Doping Agency (USADA).
The event aired in the U.S. on UFC Fight Pass.
October 9, 2015
The Brazilian Athletic Commission MMA (CABMMA) reports that four athletes were subjected to doping control tests to detect prohibited substances, per the code of the World Anti-Doping Agency (WADA), at Shooto Brazil 56, held in Rio de Janeiro on Aug. 21.
Two of the four fighters tested returned positive results.
Fabio Lima Ferreira tested positive for the stimulant methylhexaneamine and for the anabolic steroid stanozolol. Ferreira decided not to appeal the positive test results and received a two-year suspension. Ferreira lost by knock out to Mario Sartori in the fight card’s co-main event.
Main event fighter Amilcar Alves returned a positive test for 19-norandrosterone, a metabolite of the anabolic steroid nandrolone. The athlete plans to have his B sample tested to confirm the results, but his win was overturned and he received a two-year suspension. He was also forced to relinquish the welterweight title to his opponent, Rafael Viana.
The analysis of the tests was conducted at the UCLA Olympic Analytical Laboratory, and INRS-Institut Armand-Frappier, in the U.S. and Canada (certified laboratories WADA), respectively.
CABMMA is a member and follows the guidelines of the Association of Boxing Commission (ABC), and also adheres to the new anti-doping control policy of the United States Anti-Doping Agency (USADA).
The event aired in the U.S. on UFC Fight Pass.